Stéphanie Lheureux

Also affiliated with Princess Margaret Cancer Centre, Occupational Cancer Research Centre, Princess Margaret Hospital

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 6 papers. Top paper: “A randomized phase II study of cabozantinib and nivolumab versus nivolumab in recurrent endometrial cancer.”.

A randomized phase II study of cabozantinib and nivolumab versus nivolumab in recurrent endometrial cancer.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.6010

N/A

0.510DataRank · unranked

29 citations

Daniela Matei, Panagiotis A. Konstantinopoulos, Matthew S. Block, Andrea Jewell, Stéphanie Gaillard +15 more

A randomized phase II study of bevacizumab and weekly anetumab ravtansine or weekly paclitaxel in platinum-resistant or refractory ovarian cancer NCI trial#10150.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.5514

N/A

0.470DataRank · unranked

22 citations

Husam Alqaisi, David E. Cohn, Jing‐Yi Chern, Linda Duska, Andrea Jewell +15 more

Clinical parameters affecting survival outcomes in patients with low-grade serous ovarian carcinoma: an international multicentre analysis

Canadian Journal of Surgery(2023)10.1503/cjs.017020

N/A

0.286DataRank · unranked

5 citations

Marcus Q. Bernardini, Stéphanie Lheureux, Katja K.H. Aben, Elisa V. Bandera, Matthias W. Beckmann +42 more

Patient self-reporting of tolerability using PRO-CTCAE: A randomized double-blind placebo controlled phase II trial comparing gemcitabine in combination with adavosertib or placebo in women with platinum resistant epithelial ovarian cancer.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.5541

N/A

0.208DataRank · unranked

3 citations

Sandra A. Mitchell, Tyler Pittman, Lisa Wang, Valerie Bowering, Nisan Kavak +9 more

PARP Inhibitors in the Management of Ovarian Cancer: ASCO Guideline

Journal of Clinical Oncology(2020)10.1200/jco.20.01924

N/A

0DataRank · unranked

315 citations

Christina Lacchetti, Annie Ellis, Kathleen Maxian, Susana Banerjee, Michael A. Bookman +11 more

Chronic Viral Mimicry Induction following p53 Loss Promotes Immune Evasion

Cancer Discovery(2025)10.1158/2159-8290.cd-24-0094

N/A

0DataRank · unranked

19 citations

Sajid A. Marhon, Naïri Tchrakian, Anjelica Hodgson, Helen Loo Yau, Isabela M. Gonzaga +43 more